Annual SGA
$29.56 M
+$3.21 M+12.16%
December 31, 2024
Summary
- As of March 7, 2025, TCRX annual SGA is $29.56 million, with the most recent change of +$3.21 million (+12.16%) on December 31, 2024.
- During the last 3 years, TCRX annual SGA has risen by +$15.73 million (+113.76%).
- TCRX annual SGA is now at all-time high.
Performance
TCRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$7.29 M
-$114.00 K-1.54%
December 31, 2024
Summary
- As of March 7, 2025, TCRX quarterly SGA is $7.29 million, with the most recent change of -$114.00 thousand (-1.54%) on December 31, 2024.
- Over the past year, TCRX quarterly SGA has stayed the same.
- TCRX quarterly SGA is now -6.15% below its all-time high of $7.77 million, reached on June 30, 2024.
Performance
TCRX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.30 B
-$127.50 M-10.86%
December 31, 2024
Summary
- As of March 7, 2025, TCRX TTM SGA is -$1.30 billion, with the most recent change of -$127.50 million (-10.86%) on December 31, 2024.
- Over the past year, TCRX TTM SGA has dropped by -$1.33 billion (-4503.13%).
- TCRX TTM SGA is now -2889.74% below its all-time high of -$43.53 million.
Performance
TCRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
TCRX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.2% | 0.0% | -4503.1% |
| 3 y3 years | +113.8% | +23.8% | -5042.7% |
| 5 y5 years | +520.0% | +23.8% | -5042.7% |
TCRX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +113.8% | -6.2% | +64.0% | -358.8% | at low |
| 5 y | 5-year | at high | +520.0% | -6.2% | +554.9% | -2889.7% | at low |
| alltime | all time | at high | +520.0% | -6.2% | +554.9% | -2889.7% | at low |
TScan Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $29.56 M(+12.2%) | $7.29 M(-1.5%) | $29.56 M(+4.0%) |
| Sep 2024 | - | $7.41 M(-4.7%) | $28.43 M(+5.6%) |
| Jun 2024 | - | $7.77 M(+9.8%) | $26.91 M(+4.8%) |
| Mar 2024 | - | $7.08 M(+14.9%) | $25.67 M(-2.6%) |
| Dec 2023 | $26.35 M(+29.5%) | $6.16 M(+4.5%) | $26.35 M(+0.1%) |
| Sep 2023 | - | $5.89 M(-9.8%) | $26.33 M(+3.9%) |
| Jun 2023 | - | $6.53 M(-15.9%) | $25.35 M(+7.3%) |
| Mar 2023 | - | $7.77 M(+26.5%) | $23.63 M(+16.1%) |
| Dec 2022 | $20.35 M | $6.14 M(+25.1%) | $20.35 M(+9.1%) |
| Sep 2022 | - | $4.91 M(+2.1%) | $18.66 M(+4.8%) |
| Jun 2022 | - | $4.81 M(+7.0%) | $17.80 M(+13.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $4.49 M(+1.0%) | $15.72 M(+13.7%) |
| Dec 2021 | $13.83 M(+105.1%) | $4.45 M(+9.9%) | $13.83 M(+15.0%) |
| Sep 2021 | - | $4.05 M(+48.5%) | $12.02 M(+24.9%) |
| Jun 2021 | - | $2.73 M(+4.6%) | $9.62 M(+20.1%) |
| Mar 2021 | - | $2.61 M(-1.3%) | $8.01 M(+18.8%) |
| Dec 2020 | $6.74 M(+41.4%) | - | - |
| Dec 2020 | - | $2.64 M(+60.3%) | $6.74 M(+64.4%) |
| Sep 2020 | - | $1.65 M(+47.9%) | $4.10 M(+67.2%) |
| Jun 2020 | - | $1.11 M(-16.7%) | $2.45 M(+83.3%) |
| Mar 2020 | - | $1.34 M | $1.34 M |
| Dec 2019 | $4.77 M | - | - |
FAQ
- What is TScan Therapeutics annual SGA?
- What is the all time high annual SGA for TScan Therapeutics?
- What is TScan Therapeutics annual SGA year-on-year change?
- What is TScan Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for TScan Therapeutics?
- What is TScan Therapeutics quarterly SGA year-on-year change?
- What is TScan Therapeutics TTM SGA?
- What is the all time high TTM SGA for TScan Therapeutics?
- What is TScan Therapeutics TTM SGA year-on-year change?
What is TScan Therapeutics annual SGA?
The current annual SGA of TCRX is $29.56 M
What is the all time high annual SGA for TScan Therapeutics?
TScan Therapeutics all-time high annual SGA is $29.56 M
What is TScan Therapeutics annual SGA year-on-year change?
Over the past year, TCRX annual SGA has changed by +$3.21 M (+12.16%)
What is TScan Therapeutics quarterly SGA?
The current quarterly SGA of TCRX is $7.29 M
What is the all time high quarterly SGA for TScan Therapeutics?
TScan Therapeutics all-time high quarterly SGA is $7.77 M
What is TScan Therapeutics quarterly SGA year-on-year change?
Over the past year, TCRX quarterly SGA has changed by $0.00 (0.00%)
What is TScan Therapeutics TTM SGA?
The current TTM SGA of TCRX is -$1.30 B
What is the all time high TTM SGA for TScan Therapeutics?
TScan Therapeutics all-time high TTM SGA is -$43.53 M
What is TScan Therapeutics TTM SGA year-on-year change?
Over the past year, TCRX TTM SGA has changed by -$1.33 B (-4503.13%)